Found 0 matching trials
Prostate Cancer Patient Management With 18F-DCFPyL PET/CT
PHASE2This is a multi-center, single-arm, open-label, phase III trial in patients...
Status
Enrolling By Invitation
Location
Jewish General Hospital
Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical Prostatectomy
NAThis pilot study aims to investigate the diagnostic utility of 18F-DCFPyL, ...
PSMA PET and MRI in Gynecological Cancers
PHASE2The goal of this research is to determine the accuracy of PSMA positron emi...
Location
University of Wisconsin, Madison
Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial
PHASE2This phase II trial tests how well relugolix and enzalutamide, in combinati...
Location
Northwestern University
PET/MRI for the Staging of Newly Diagnosed Prostate Cancer
EARLY_PHASE1The purpose of this study is to gain understanding of how PET-MR (positron ...
Status
Active Not Recruiting
Location
Northwestern University
Piflufolastat F 18 PET/CT in Patients With Suspected, or at High Risk for Metastatic ccRCC
PHASE2This study is being conducted to test whether an imaging technique called a...
Location
Washington University in St. Louis
Multimodal Machine Learning Characterization of Solid Tumors
N/AThis research study wants to develop advanced imaging methods to more accur...
Location
Massachusetts General Hospital
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer
PHASE2Background:
Prostate cancer is the second leading cause of cancer deaths i...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
PSMA PET Registry (18F-DCFPyL)
NAThe purpose of the Princess Margaret Cancer Centre PSMA registry is to asse...
Location
Princess Margaret Cancer Centre
Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer
PHASE3This randomized phase III trial studies the success rate of definitive radi...
Location
UCLA / Jonsson Comprehensive Cancer Center